Affiliation:
1. Department of Design in Engineering, University of Vigo, 36208 Vigo, Spain
2. Design, Expert Systems and Artificial Intelligent Solutions Group (DESAINS), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36213 Vigo, Spain
3. Center for Health Technologies and Information Systems Research—CINTESIS, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
Abstract
Breast cancer is the most frequently diagnosed tumor pathology on a global scale, being the leading cause of mortality in women. In light of this problem, screening programs have been implemented on the population at risk in the form of mammograms, starting in the 20th century. This has considerably reduced the associated deaths, as well as improved the prognosis of the patients who suffer from this disease. In spite of this, the evaluation of mammograms is not without certain variability and depends, to a large extent, on the experience and training of the medical team carrying out the assessment. With the aim of supporting the evaluation process of mammogram images and improving the diagnosis process, this work presents the design, development and proof of concept of a novel intelligent clinical decision support system, grounded on two predictive approaches that work concurrently. The first of them applies a series of expert systems based on fuzzy inferential engines, geared towards the treatment of the characteristics associated with the main findings present in mammograms. This allows the determination of a series of risk indicators, the Symbolic Risks, related to the risk of developing breast cancer according to the different findings. The second one implements a classification machine learning algorithm, which using data related to mammography findings as well as general patient information determines another metric, the Statistical Risk, also linked to the risk of developing breast cancer. These risk indicators are then combined, resulting in a new indicator, the Global Risk. This could then be corrected using a weighting factor according to the BI-RADS category, allocated to each patient by the medical team in charge. Thus, the Corrected Global Risk is obtained, which after interpretation can be used to establish the patient’s status as well as generate personalized recommendations. The proof of concept and software implementation of the system were carried out using a data set with 130 patients from a database from the School of Medicine and Public Health of the University of Wisconsin-Madison. The results obtained were encouraging, highlighting the potential use of the application, albeit pending intensive clinical validation in real environments. Moreover, its possible integration in hospital computer systems is expected to improve diagnostic processes as well as patient prognosis.
Reference52 articles.
1. Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040;Arnold;Breast,2022
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021
3. Understanding Breast Cancer as a Global Health Concern;Wilkinson;Br. J. Radiol.,2021
4. Sickles, E.A., D’Orsi, C.J., Bassett, L.W., Appleton, C.M., Berg, W.A., Burnside, E.S., Feig, S.A., Gavenonis, S.C., Newell, M.S., and Trinh, M.M. (2013). Atlas BI-RADS del ACR, Sistema Normalizado para la Redacción de Informes de Estudios por Imágenes de la Mama, Colegio Estadounidense de Radiología.
5. Variability in Interpretive Performance at Screening Mammography and Radiologists’ Characteristics Associated with Accuracy;Elmore;Radiology,2009